Schmidt Eric Thomas Insider Trades

Insider Trading History

Track insider trading activity for Schmidt Eric Thomas. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Revolution Medicines- Warrants (17/12/2026)
Revolution Medicines- Warrants (17/12/2026) RVMDW
Director
Holding Value $115k 18,400 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$6.26
Revolution Medicines- Warrants (17/12/2026)
Revolution Medicines- Warrants (17/12/2026) RVMDW
Director
Holding Value $133k 21,251 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$6.26
Revolution Medicines
Revolution Medicines RVMD
Director
Holding Value $2.87M 18,400 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$457k 18,400 shares
$24.84
$155.99
Revolution Medicines
Revolution Medicines RVMD
Director
Holding Value $3.31M 21,251 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 5,200 shares
$24.84
$155.99
Relmada Therapeutics
Relmada Therapeutics RLMD
Director
Holding Value $950k 150,000 shares
Last Trade
May 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$264k 92,958 shares
$2.84
$6.33
Allogene Therapeutics
Allogene Therapeutics ALLO
Chief Financial Officer
Holding Value $1.72M 862,439 shares
Last Trade
Mar 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.18M 432,738 shares
$5.04
$2.00
Allogene Therapeutics
Allogene Therapeutics ALLO
Chief Financial Officer
Holding Value $609k 304,345 shares
Last Trade
Mar 14, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$196k 35,879 shares
$5.47
$2.00
Relmada Therapeutics
Relmada Therapeutics RLMD
Director
Holding Value $361k 57,042 shares
Last Trade
Dec 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$192k 57,042 shares
$3.37
$6.33
Revolution Medicines- Warrants (17/12/2026)
Revolution Medicines- Warrants (17/12/2026) RVMDW
Director
Holding Value $100k 16,051 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$6.26
Revolution Medicines
Revolution Medicines RVMD
Director
Holding Value $2.5M 16,051 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87.4k 5,200 shares
$16.80
$155.99
Relmada Therapeutics
Relmada Therapeutics RLMD
Director
Holding Value $950k 150,000 shares
Last Trade
May 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.74M 91,235 shares
$19.03
$6.33
Allogene Therapeutics
Allogene Therapeutics ALLO
Director, Chief Financial Officer
Holding Value $676k 337,904 shares
Last Trade
Mar 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.3M 237,358 shares
$9.69
$2.00
Allogene Therapeutics
Allogene Therapeutics ALLO
Director, Chief Financial Officer
Holding Value $201k 100,546 shares
Last Trade
Mar 15, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$87.5k 11,469 shares
$7.63
$2.00
Relmada Therapeutics
Relmada Therapeutics RLMD
Director
Holding Value $372k 58,765 shares
Last Trade
Dec 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.12M 58,765 shares
$19.03
$6.33
Revolution Medicines- Warrants (17/12/2026)
Revolution Medicines- Warrants (17/12/2026) RVMDW
Director
Holding Value $79.2k 12,659 shares
Last Trade
Jun 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$6.26
Revolution Medicines- Warrants (17/12/2026)
Revolution Medicines- Warrants (17/12/2026) RVMDW
Director
Holding Value $67.9k 10,851 shares
Last Trade
Jun 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$6.26
Revolution Medicines
Revolution Medicines RVMD
Director
Holding Value $1.97M 12,659 shares
Last Trade
Jun 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$417k 12,659 shares
$32.93
$155.99
Revolution Medicines
Revolution Medicines RVMD
Director
Holding Value $1.69M 10,851 shares
Last Trade
Jun 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119k 3,617 shares
$32.93
$155.99
Allogene Therapeutics
Allogene Therapeutics ALLO
Chief Financial Officer
Holding Value $189k 94,703 shares
Last Trade
May 24, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$375k 14,897 shares
$25.18
$2.00
Allogene Therapeutics
Allogene Therapeutics ALLO
Chief Financial Officer
Holding Value $222k 110,994 shares
Last Trade
May 24, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$375k 14,897 shares
$25.18
$2.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up